--- title: "Sito Bio: The listing application for the chemical raw material drug Methylprednisolone has been approved" type: "News" locale: "en" url: "https://longbridge.com/en/news/263971583.md" description: "Sito Bio's holding subsidiary, Shandong Sray Pharmaceutical Co., Ltd., recently received approval from the National Medical Products Administration for the marketing application of methylprednisolone chemical raw materials. Methylprednisolone is a medium-acting, halogen-free corticosteroid medication suitable for emergency treatment and management of various diseases, including endocrine disorders, rheumatic diseases, and skin diseases" datetime: "2025-11-03T08:57:32.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/263971583.md) - [en](https://longbridge.com/en/news/263971583.md) - [zh-HK](https://longbridge.com/zh-HK/news/263971583.md) generator: "portal-rs" --- # Sito Bio: The listing application for the chemical raw material drug Methylprednisolone has been approved According to the Zhitong Finance APP, Sito Bio (300583.SZ) announced that its controlling subsidiary, Shandong Sray Pharmaceutical Co., Ltd., recently received the Approval Notice for the Market Application of Methylprednisolone issued by the National Medical Products Administration. Methylprednisolone is a medium-acting, halogen-free corticosteroid used for emergency treatment of critical illnesses, and it can also be used for endocrine disorders, rheumatic diseases, collagen diseases, skin diseases, allergic reactions, ophthalmic diseases, gastrointestinal diseases, blood diseases, leukemia, shock, cerebral edema, multiple neuritis, myelitis, and to prevent vomiting caused by cancer chemotherapy ### Related Stocks - [300583.CN](https://longbridge.com/en/quote/300583.CN.md) ## Related News & Research - [LEAD Launch Leaves Accountable Care Technology Buyers Little Time for a Wrong Decision, Q3 Study](https://longbridge.com/en/news/296106866.md) - [Focus Media Information Technology Co: Net profit jumped 17.39% to ¥3.13 billion despite a slight revenue dip, with strong cash flow](https://longbridge.com/en/news/296251196.md) - [09:03 ETPlayOn Sports Brings the Nation's Top High School Football Games to Fans Nationwide with 2026 MaxPreps Game of the Week](https://longbridge.com/en/news/296621737.md) - [DAZN becomes Indiana Pacers’ exclusive regional streaming partner for 2026-27 season](https://longbridge.com/en/news/296538501.md) - [BUZZ-Faeth Therapeutics rises after FDA grants fast-track status for cancer drug](https://longbridge.com/en/news/296104768.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**